Skip to main content

RespireRx Pharmaceuticals, Inc. (RSPI)

OTCMKTS: RSPI · IEX Real-Time Price · USD
0.0232 0.0007 (3.11%)
Oct 25, 2021 3:40 PM EDT - Market closed
Market Cap2.10M
Revenue (ttm)n/a
Net Income (ttm)-5.64M
Shares Out89.83M
EPS (ttm)-0.09
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume385,009
Open0.0232
Previous Close0.0225
Day's Range0.0210 - 0.0232
52-Week Range0.0200 - 0.0790
Beta0.27
Analystsn/a
Price Targetn/a
Earnings Daten/a

About RSPI

RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. It has two drug platforms comprising ResolutionRx, a pharmaceutical cannabinoids platform, which includes dronabinol that acts upon the nervous system's endogenous cannabinoid receptors for use in refractory chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS; and EndeavourRx, a neuromodulators platform that comprises AMPAkines program, inc...

IndustryPharmaceuticals
Founded1987
Employees3
Stock ExchangeOTCMKTS
Ticker SymbolRSPI
Full Company Profile

Financial Performance

Financial Statements

News

RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference

Glen Rock, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB Market: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolut...

4 months ago - GlobeNewsWire

RespireRx Pharmaceuticals Inc. Announces New Data Regarding the Use of AMPAkines as Potential Treatments for Spinal C...

Glen Rock, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary t...

5 months ago - GlobeNewsWire

RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs

Glen Rock, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary...

6 months ago - GlobeNewsWire

Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI

Glen Rock, N.J., Feb. 08, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company” or “we”), has been up listed from the OTC Pink Market and returns to the OTC...

8 months ago - GlobeNewsWire